Armata Pharma shares jump on FDA breakthrough designation
Armata Pharmaceuticals’ shares rose in premarket after the FDA granted breakthrough therapy designation for a potential antibacterial treatment.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.